Membership
 ICO Bylaws
Abstracts
Program
Photo Gallery
Contact:
Dr. Anja Tuulonen
anja.tuulonen@ppshp.fi
Download Final Program & Abstracts

Download PDF File - PDF format 5.27 Megabytes
Click to open or 'Right Click' and select 'Save As'

Adobe Acrobat Reader must be installed on your system to view and print. This is a free download.
Meeting of the Glaucoma Society of the International Congress of Ophthalmology, May 29-31, 2003

LOCATION: Château Hotel Montroyal, Chantilly, France

MEETING OVERVIEW: Normal format excepting two mini-symposia with designated organizers and invited discussants:
 
Thursday AM
0800 – 1000 Mini-symposium #1
  1030 – 1200 Free Papers
 
Thursday PM
1200 - 1400 Business Meeting
  1400 - 1700 Free papers and posters
 
Friday AM
0800 – 1230 Mini-symposium #2
 
Friday PM
1330 - 1500 Free papers and posters
 
Saturday AM & PM
0800 - 1200 Free papers and posters
MINI-SYMPOSIUM #1
“Definitive” Definitions and Diagnostic Criteria for Primary Open-Angle Glaucoma. “The Chantilly Standards”
Thursday May 29, 0800 -1000
Premise: Clarity of language and communication clarifies thought.

We may now have sufficient data to clarify our communications (and our thoughts) concerning the definitions and diagnostic criteria for open angle glaucoma, its severity and its progression. Custom and habit continue to perpetuate unnecessary variability and confusion.
This mini-symposium will propose standard definitions and criteria and explore whether sufficient consensus exists to support conformity in their use in future scientific publications and discussion.
 
0800 - 0805 Introduction: Don Minckler - Moderator
  0805 – 0815 Paul Foster: IOP, its measurement, “adjustment”, and interpretation
  0815 – 0820 Franz Grehn: Discussion/counterpoint
  0820 – 0830 Open Discussion
  0830 – 0840 Anne Coleman: Relationship between IOP and COAG, and implications for terminology (NTG, LTG, OH)
  0840 – 0845 Yoshiaki Kitazawa: Discussion/counterpoint
  0845 – 0855 Open Discussion
  0855 – 0905 Douglas Anderson: Definition and minimal elements/parameters for the diagnosis of POAG, for individuals at greater than average risk of developing POAG
  0905 - 0910 Harry Quigley: Discussion/counterpoint
  0910 – 0920 Open Discussion
  0920 – 0930 Rohit Varma: Definition and data elements/parameters for defining progressive POAG
  0930 – 0935 Carlo Traverso: Discussion/counterpoint
  0935 – 0955 Open Discussion
  0955 - 1000 Don Minckler: Summary
  Chair: Summary
MINI-SYMPOSIUM #2
Randomized Controlled Trials of Therapy in Glaucoma
Friday May 30, 0800 – 1000
Premise: Randomized controlled trials (RCTs) have evolved into the principal source of high quality evidence for determining the efficacy of therapy.

Continued analysis of RCT results, past and ongoing, is crucial to present treatment and future research planning. During this session, synopses of “what we have learned” and “focused critiques” of recent RCTs will be presented to stimulate group discussion.
 
0800 - 0802 Introduction: Don Minckler
  0802 – 0805 Goals of the Symposium
Moderator/Organizer: Roger Hitchings
 
RCT’s in Glaucoma

a) Treatment vs. No Treatment

0805 – 0815 Doug Anderson: The Collaborative NTG study
  0815– 0825 Anders Heijl: The Early Manifest Glaucoma Study
  0825– 0855 Open Discussion

b) Initial Treatments

0855 - 0905 M. Roy Wilson: The Glaucoma Laser Trial
  0905 - 0915 Dale Heuer: The Collaborative Initial Glaucoma Treatment Study (CIGTS)
  0915 - 0925 Mike Kass: The Ocular Hypertensive Treatment Study
  0925 – 0955 Open Discussion
  Coffee Break

c) Later Treatments

1030 - 1040 Paul Palmberg: The AGIS Study
  1040 - 1050 Peng Khaw: The Moorfields 5-FU Study
  1050 - 1120 Open Discussion
 
Global Perspectives on RCTs
 
1120 - 1130 M. Roy Wilson: A North American view
  1130 – 1140 M. Araie: An Asian view
  1140 – 1150 Ravi Thomas: An Indian view
  1150 – 1220 Open Discussion
  1220 – 1230 Roger Hitchings: Summary and conclusions
  1230 Lunch

Updated: December 8, 2008 4:03 PM AST